SYNTHESIS MED CHEM (UK) LIMITED
ActiveKey figures
Ratios
2025Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: SYNTHESIS MED CHEM (UK) LIMITED
What kind of company is it?
SYNTHESIS MED CHEM (UK) LIMITED is a private limited company registered with Companies House under company number 07624460. It was incorporated on 6 May 2011. Its status is active. The registered office is in London (W1B). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files medium company accounts. Turnover was £629,087. Loss for the year was £117,338. Net assets were −£25,843, down 128.2% on the previous year. Cash at bank and in hand was £229,927. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2025).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By turnover it ranks lower than 66% of the 146 that publish turnover (median £2,577,327). By net assets it ranks lower than 78% of them (median £20,978). By total assets it ranks higher than 83% of them (median £125,654). By cash it ranks higher than 60% of them (median £101,976). By number of employees it ranks higher than 81% of them (median 1). It is older than 87% of them (median age 5.4 years).
Who runs and controls the company?
The company has 3 current directors.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 26 Mar 2027.
Filed accounts2019/20–2025
| 2020/21 | 2021/22 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 426,013 | 409,489 | 1,129,028 | 1,299,252 | 629,087 |
| Profit for the year | 46,224 | -161,329 | 39,786 | 17,491 | -117,338 |
| Cash at bank and in hand | 583,261 | 802,390 | 1,282,710 | 1,478,582 | 229,927 |
| Total assets | 2,096,080 | 2,089,114 | 2,702,303 | 2,892,185 | 2,976,575 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 195,547 | 34,218 | 74,004 | 91,495 | -25,843 |
| Average number of employees | 3 | 1 | 4 | 5 | 5 |
| Average pay (per year) | 48,635 | 145,834 | 104,554 | 67,541 | 91,384 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
28 events- Viva Biotech Holdigs Ltd ceased to be a person with significant control
- Financial year 2025 endedAccounts: turnover £629.1k, net assets −£25.8k, 5 employees
- Financial year 2024 endedAccounts: turnover £1.3m, net assets £91.5k, 5 employees
- Financial year 2023 endedAccounts: turnover £1.1m, net assets £74k, 4 employees
- Zhixiong YE resignedDirector
- Daniel Ning MAO appointedDirector
- Viva Biotech Holdigs Ltd registered as a person with significant control
- Mr Chen Cheney Mao ceased to be a person with significant control
Earlier events (20)
- Simon Andrew BURY appointedDirector
- Zhixiong YE appointedDirector
- Financial year 2021/22 endedAccounts: turnover £409.5k, net assets £34.2k, 1 employee
- Financial year 2020/21 endedAccounts: turnover £426k, net assets £195.5k, 3 employees
- Andrew Frederick WILKS resignedDirector
- Mr Chen Cheney Mao registered as a person with significant control
- Mr Andrew Frederick Wilks ceased to be a person with significant control
- Simon Andrew BURY resignedDirector
- Financial year 2019/20 endedAccounts: net assets £149.3k, 3 employees
- Simon Andrew BURY appointedDirector
- Nigel Grahame RAMSDEN resignedDirector
- Mr Andrew Frederick Wilks registered as a person with significant control
- Nigel Grahame RAMSDEN appointedDirector
- Michael DYSON resignedDirector
- Barbara KAHAN resignedDirector
- Xianyong BU appointedDirector
- Michael DYSON appointedDirector
- Barbara KAHAN appointedDirector
- Andrew Frederick WILKS appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.